Literature DB >> 1622185

Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.

J V Etzel1, A N Nafziger, J S Bertino.   

Abstract

The pharmacokinetic parameters of gentamicin and tobramycin were evaluated and compared for 260 patients with pleural effusions and 1,049 patients without pleural effusions by chest radiograph. Pharmacokinetic data were collected prospectively and analyzed by using our aminoglycoside data base. Univariate analysis revealed that the patients with pleural effusions demonstrated significantly lower serum albumin concentrations, greater aminoglycoside volumes of distribution, longer elimination half-lives, and lower peak and higher trough concentrations in serum than the patients without pleural effusions. Patients with pleural effusions were significantly older and had lower total body weight. Stepwise multiple linear regression analysis revealed that lower total body weight and serum albumin concentration, presence of pleural effusion, and greater age were associated with significantly greater volumes of distribution. Calculated creatinine clearance, age, total body weight, and shock were associated with reduced aminoglycoside clearance in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622185      PMCID: PMC190580          DOI: 10.1128/AAC.36.3.679

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Gentamicin dosing requirements in patients with acute pancreatitis.

Authors:  M R Carr; S P Dick; J Bordley; J S Bertino
Journal:  Surgery       Date:  1988-05       Impact factor: 3.982

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

Authors:  R J Sawchuk; D E Zaske
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 4.  Basic pharmacokinetics.

Authors:  R H Levy; L A Bauer
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

5.  Clinico-pharmacological examination of gentamycin in thoracic surgery.

Authors:  J I Kiss; E Faragó; L Kónya; E Fábián; F Móricz
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-10

6.  Gentamicin pharmacokinetics in patients with malignancies.

Authors:  J S Bertino; L A Booker; P Franck; B Rybicki
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.

Authors:  R D Moore; P S Lietman; C R Smith
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

8.  Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care.

Authors:  P W Niemiec; M D Allo; C F Miller
Journal:  Arch Surg       Date:  1987-02

9.  Increased dosage requirements of gentamicin in burn patients.

Authors:  D E Zaske; R J Sawchuk; D N Gerding; R G Strate
Journal:  J Trauma       Date:  1976-10

10.  Altered gentamicin distribution in ascitic patients.

Authors:  M A Gill; J W Kern
Journal:  Am J Hosp Pharm       Date:  1979-12
View more
  8 in total

Review 1.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.

Authors:  E Triggs; B Charles
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 3.  Pharmacological considerations for the proper clinical use of aminoglycosides.

Authors:  Spyridon Pagkalis; Elpis Mantadakis; Michael N Mavros; Christina Ammari; Matthew E Falagas
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

4.  Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.

Authors:  D Beauchamp; P Collin; L Grenier; M LeBrun; M Couture; L Thibault; G Labrecque; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

5.  Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.

Authors:  Duangchit Panomvana; Sam-Ang Kiatjaroensin; Danabhand Phiboonbanakit
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

6.  Aminoglycoside dosing weight correction factors for patients of various body sizes.

Authors:  A M Traynor; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

7.  Population pharmacokinetics of gentamicin in patients with cancer.

Authors:  M C Rosario; A H Thomson; D I Jodrell; C A Sharp; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

Review 8.  Effects of surgery on the pharmacokinetic parameters of drugs.

Authors:  J M Kennedy; A M Riji
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.